Navigation Links
Georgetown Lombardi researchers present new findings on head & neck cancers
Date:1/26/2012

WASHINGTON, DC Research physicians from Georgetown Lombardi Comprehensive Cancer Center will present new data about a complex group of cancers known as head and neck cancers at the Multidisciplinary Head and Neck Cancer Symposium, January 26 through 28, in Phoenix, Arizona.

Should patients with HPV+ head and neck cancers receive less chemotherapy?

Georgetown researchers are examining a hypothesis about whether HPV+ patients with a head and neck cancer should receive more or less chemotherapy.

"Given the rising number of patients with HPV-caused head and neck cancers, we need to find the right way to treat and cure, this disease," explains John Deeken, M.D., director of head and neck medical oncology at Georgetown Lombardi. "Some argue that we should decrease the intensity of treatment given how well HPV-positive cancers respond to treatment. Our research suggests the opposite -- that intensifying therapy in high-risk HPV-positive patients might well increase the cure rate of this disease. Clearly additional clinical studies are warranted to further test our findings." (See study abstract below.)

Examining a rare sequel of head and neck cancer axillary node metastasis

In a separate study, researchers are studying an unusual occurance linked to head and neck tumors involving metastasis in the axillary nodes.

"It is postulated that this can be secondary to tumor blockage at the jugulo-subclavian junction and/or fibrosis of the cervical lymphatics following surgery or radiation therapy resulting in retrograde lymphatic flow," says Richard H. Comstock III, M.D, a 4th-year resident in the department of otolaryngology at MedStar Georgetown University Hospital. "Upon reviewing the patients in our series we found that they all had manipulation of their neck lymphatics with either surgery or radiation which we believe played a role in the development of axillary metastasis. In addition we present the only known case of axillary metastasis from a squamous cell skin malignancy."

Comstock adds, "Clinicians should be aware of this potential complication of head and neck cancer an screen high risk patients accordingly." (See study abstract below.)
'/>"/>

Contact: Karen Mallet
km463@georgetown.edu
Georgetown University Medical Center
Source:Eurekalert

Related medicine news :

1. Georgetown University Medical Center licenses theranostic for development
2. Georgetown professor applauds decision of researchers to temporarily halt research on H5N1
3. Georgetown researchers examine 21-year series of nipple sparing mastectomy cases and find no cancers
4. FDA awards Georgetown University a Center of Excellence in Regulatory Science & Innovation
5. Georgetown research identifies key reasons racial disparities exist in emergent stroke treatment
6. FDA and Georgetown University Medical Center announce partnership
7. Georgetown Research Center Helps Reporters Decipher Health Reform Law & Impact on State Residents
8. Georgetown University Center for Children and Families Hails Health Reform As Big Win for Children and Families
9. Lombardi research: Robotic radiosurgery offers palliative care for hilar lung tumors
10. Susan G. Komen for the Cure awards grant to Lombardis V. Craig Jordan
11. Lombardi research teams hone in on treatments for osteosarcoma and Ewings sarcoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... Lewisville, TX (PRWEB) , ... June 25, 2016 , ... ... in the United States, named Dr. Sesan Ogunleye, as the Medical Director of its ... be the facility Medical Director of our new Mesquite location,” said Dr. James M. ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, ... at Work award to iHire in recognition of their exemplary accomplishments in worksite health ... annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals plc ... period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, ... of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ... (Eastern Daylight Time). As previously announced on ... a definitive merger agreement under which Jazz Pharmaceuticals has ...
(Date:6/24/2016)... N.C. , June 24, 2016  Consumers ... decisions and regulators/payers have placed more emphasis on ... environment, patient support programs in the pharmaceutical industry ... patients, medications. Consequently, pharmaceutical companies are focusing on ... they are providing products and services that improve ...
(Date:6/24/2016)...   Bay Area Lyme Foundation , collaborating ... for Tick Borne Illness , Harvard Medical School ... Medicine, University of California, Berkeley, and the Veterans ... finalists of Lyme Innovation , the first ... scientists, clinicians, researchers, entrepreneurs, and investors from several ...
Breaking Medicine Technology: